Overview Request Sample Pages Request Customization Download PDF
You are viewing: China Transplant Diagnostics Market analysis
Part of: Transplant Diagnostics Market (Global)

The China Transplant Diagnostics Market was valued at $55.4 Million in 2026 and projected to reach to $62.9 Million by 2031, representing a compound annual growth rate of CAGR 5.9%. China's transplant diagnostics market is positioned for substantial growth as the nation strengthens its organ transplant infrastructure and healthcare capabilities.

China Transplant Diagnostics Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Transplant Diagnostics Market Trends and Insights

  • This steady growth reflects Europe's advanced healthcare infrastructure, increasing organ transplant volumes, and rising adoption of precision diagnostic technologies across the region.
  • Europe's mature healthcare systems and strong regulatory frameworks support the deployment of innovative transplant diagnostic solutions. The European market benefits from high healthcare spending, well-established transplant centers, and growing awareness of the importance of pre- and post-transplant diagnostics.
  • Europe's aging population and prevalence of organ failure conditions drive demand for transplant procedures, which in turn increases the need for sophisticated diagnostic tools.
  • Between 2026 and 2031, Europe is positioned to capture significant market share through investments in immunosuppressive monitoring, HLA typing, and donor-recipient compatibility testing. Key European markets, including Germany, France, the United Kingdom, and Spain, are leading adoption of advanced transplant diagnostic platforms.
  • Europe's regulatory environment and reimbursement policies continue to support market expansion, making the region a critical hub for transplant diagnostics innovation and clinical implementation..

Key Market Statistics

  • CAGR (2026-2031) CAGR 5.9%
  • Market Size, 2026 ~USD 55.4 Million
  • Forecast, 2031 ~USD 62.9 Million
  • Country China

China Transplant Diagnostics Market Overview

Rapid Market Expansion :

China's transplant diagnostics market is experiencing accelerated growth driven by increasing organ transplant procedures, government healthcare reforms, and rising investment in diagnostic infrastructure across major cities.

Government Support & Policy :

China's national organ transplant program and healthcare modernization initiatives are creating favorable conditions for advanced diagnostic adoption, with regulatory frameworks increasingly supporting precision medicine technologies.

Rising Transplant Volumes :

Growing demand for organ transplants due to aging population and lifestyle-related diseases is driving the need for sophisticated pre- and post-transplant diagnostic solutions in Chinese healthcare facilities.

Technology Adoption Gap :

Significant opportunity exists as Chinese hospitals and diagnostic centers increasingly adopt international-standard transplant diagnostics technologies to improve transplant outcomes and reduce rejection rates.

China Transplant Diagnostics Market Dynamics

  • Government initiatives promoting organ donation and transplantation, combined with rising healthcare spending, are creating robust demand for advanced diagnostic solutions.
  • The market benefits from increasing collaboration between Chinese medical institutions and international diagnostic providers, facilitating technology transfer and localization. Key growth drivers include expanding transplant centers in tier-2 and tier-3 cities, growing awareness of precision diagnostics among healthcare professionals, and rising patient demand for improved transplant outcomes.
  • As China continues modernizing its healthcare system and investing in diagnostic innovation, the transplant diagnostics sector is expected to capture significant market share, particularly in HLA typing, immunosuppressant monitoring, and rejection detection technologies..

Related Ecosystem

In Vitro Diagnostics

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Dna Microarrays
  • Assay Kits
  • Microarrays
Top Companies
  • ROCHE HOLDINGS AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Biomerieux s.a.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • Europe's transplant diagnostics market is valued at $55.4 million in 2026 and projected to reach $62.9 million by 2031 at a 5.9% CAGR.
      • Europe's advanced healthcare infrastructure and high transplant volumes drive steady demand for diagnostic innovations across the region.
      • HLA typing, immunosuppressive monitoring, and donor-recipient compatibility testing are key growth drivers in Europe's transplant diagnostics sector.
      • Europe's mature regulatory environment and strong reimbursement policies support sustained market expansion through 2031.

      Transplant Diagnostics Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment NEXT-GENERATION SEQUENCING (NGS) (Application)
      Forecast Period 2026–2031
      Growth Rate CAGR of 7.8% from 2026 to 2031
      Largest Segment INDEPENDENT REFERENCE LABORATORIES (Type)
      Market Size Base Year (Billions) ~USD 5.59 (2026)
      Revenue Forecast (Billions) ~USD 8.14 (2031)
      Segments Covered Product & Service, Application, End User, Type, Transplant Type, Technology

      China Transplant Diagnostics Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Product & Service

      • Instruments
      • Reagents & Consumables
      • Software & Services

      By Application

      • Blood Profiling
      • Diagnostic Applications
      • Histocompatibility Testing
      • Infectious Disease Testing
      • Post-Transplantation Diagnostics
      • Research Applications

      By End User

      • Hospitals & Surgical Centers
      • Hospitals & Transplant Centers
      • Independent Reference Laboratories
      • Research Laboratories & Academic Institutes

      By Type

      • Blood Profiling
      • Bone Marrow Transplantation
      • Heart
      • Heart Transplantation
      • Histocompatibility Testing
      • Infectious Disease Testing
      • Kidney
      • Kidney Transplantation
      • Liver
      • Liver Transplantation
      • Lung
      • Lung Transplantation
      • Next-Generation Sequencing (Ngs)
      • Ngs
      • Other Organs
      • Other Pcr-Based Molecular Assays
      • Other Sequencing Technologies
      • Other Sequencing-Based Molecular Assays
      • Other Solid Organ Transplantation
      • Pancreas
      • Pancreas Transplantation
      • Post-Transplantation Diagnostics
      • Pre-Transplantation Diagnostics
      • Real-Time Pcr
      • Sanger Sequencing
      • Sequence-Specific Oligonucleotide-Pcr (Sso-Pcr)
      • Sequence-Specific Primer-Pcr (Ssp-Pcr)
      • Soft Tissue Transplantation
      • Solid Organ Transplantation
      • Stem Cell Transplantation

      By Transplant Type

      • Bone Marrow Transplantation
      • Heart
      • Kidney
      • Liver
      • Lung
      • Other Organs
      • Pancreas
      • Soft Tissue Transplantation
      • Solid Organ Transplantation
      • Stem Cell Transplantation

      By Technology

      • Non-Molecular Assay Technologies
      • Pcr-Based Molecular Assays
      • Sequencing-Based Molecular Assays

      CHINA: TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2024–2031

      Segment20242025202620272028202920302031CAGR (%)
      HOSPITALS & TRANSPLANT CENTERS107.4116.4126.7138.4151.5166.3182.7201.49.7
      INDEPENDENT REFERENCE LABORATORIES192.2208.7227.6249273.1300.2330.6364.99.9
      RESEARCH LABORATORIES & ACADEMIC INSTITUTES18.920.422.124.126.428.931.734.89.5
      TOTAL318.5345.5376.4411.5450.9495.4545601.19.8

      Target Audience

      • Diagnostic Equipment Manufacturers : Need market intelligence on China's transplant diagnostics demand, competitive positioning, and technology preferences to develop localized products and establish distribution partnerships in this growing market.
      • Healthcare Investors & PE Firms : Require detailed market sizing, growth forecasts, and investment landscape analysis to identify acquisition targets and fund allocation opportunities in China's transplant diagnostics sector.
      • Hospital & Transplant Center Administrators : Need insights on diagnostic technology trends, best practices, and market benchmarks to optimize transplant program capabilities and make informed procurement decisions for diagnostic solutions.
      • Pharmaceutical & Biotech Companies : Seek understanding of immunosuppressant monitoring and rejection detection market dynamics in China to support clinical trial strategies and companion diagnostic development initiatives.
      • Healthcare Consultants & Strategy Firms : Require comprehensive China-specific market data and trend analysis to advise clients on market entry strategies, competitive positioning, and growth opportunities in transplant diagnostics.

      Key Companies in the China Transplant Diagnostics Market

      CompanyHQOwnershipStrongest segments
      KINDRED HEALTHCARE INC.United StatesPrivate CompanyLong-term acute care hospitals (LTACH) – drug-intensive episodes,Inpatient rehabilitation facilities – medically complex rehab,Contract rehabilitation services in third-party facilities,
      UNILABSSwitzerlandPrivate CompanyCore laboratory testing,Medical imaging,Pathology and centres of excellence,
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science,
      QIAGEN N.V.NetherlandsPublic CompanySample technology consumables and instruments,Molecular diagnostics (immune response, oncology, sexual and reproductive health),PCR and enzymes (research and applied testing),
      BIOMéRIEUXFrancePublic CompanyClinical microbiology (VITEK, BACT/ALERT, culture media, ETEST, API),Molecular diagnostics (BIOFIRE, SPOTFIRE, ARGENE, EMAG/NUCLISENS),Immunoassay and biomarkers (VIDAS, Hybiome CLIA),
      ILLUMINA, INC.United StatesPublic CompanySequencing instruments,Sequencing consumables (reagents, flow cells, library prep),Array-based instruments and consumables,
      BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyMedical Essentials (syringes, needles, vascular access, sharps, basic disposables),Connected Care (infusion therapy, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery, closed-system transfer devices),
      CAREDX, INC.United StatesPublic Companydd-cfDNA transplant surveillance (AlloSure Kidney/Heart/Lung, AlloSeq cfDNA, AlloHome),Gene expression and multimodal testing (AlloMap Heart, HeartCare, HistoMap Kidney, AlloHeme),HLA typing and transplant lab solutions (QTYPE, Olerup SSP, AlloSeq Tx, AlloSeq HCT, Allocell),
      DIASORIN S.P.A.ItalyPublic CompanyImmunodiagnostics – Infectious and Gastrointestinal Diseases,Immunodiagnostics – Endocrinology and Metabolic Disorders,Oncology and Tumor Markers,
      MERCK KGAAGermanyPublic CompanyLife Science (reagents, consumables, instruments, bioprocessing, CDMO),Healthcare (oncology, neurology & immunology, fertility, rare diseases),Electronics (semiconductor and display materials, specialty gases, equipment),
      HOLOGIC, INC.United StatesPrivate CompanyDiagnostics (Aptima, Panther, ThinPrep, fetal fibronectin),Breast Health (3D mammography, biopsy, localization, software),GYN Surgical (MyoSure, NovaSure, Fluent, Acessa, CoolSeal),
      EUROBIO SCIENTIFICFrancePublic CompanyInfectious disease & molecular biology (EBX, EurobioPlex, biosafety),Transplantation & immunology (AlloMap, GenDx, immunology products),Oncology diagnostics (EndoPredict, Prolaris),

      KINDRED HEALTHCARE INC.

      Kindred Healthcare Inc. is a large private healthcare services company founded in 1985 in the United States, employing 64,200 people. The company operates in the healthcare and medical services sector.

      UNILABS

      Unilabs is a private laboratory and diagnostics company founded in 1987 in Switzerland with 1,897 employees. The company offers clinical laboratory and diagnostic testing services.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a public multinational life sciences company founded in 1956 in the United States with 125,000 employees. The company provides laboratory equipment, reagents, and analytical instruments globally.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a public life sciences and clinical diagnostics company founded in 1952 in the United States with 7,450 employees. The company manufactures and distributes products for the clinical laboratory and life sciences research markets.

      QIAGEN N.V.

      QIAGEN N.V. is a public molecular diagnostics and life sciences company founded in 1984 in the Netherlands with 5,500 employees. The company provides sample and assay technologies for molecular diagnostics and research.

      BIOMéRIEUX

      bioMérieux is a public in vitro diagnostics company founded in 1963 in France with 14,894 employees. The company specializes in microbiology and immunoassay diagnostic solutions.

      ILLUMINA, INC.

      Illumina, Inc. is a public genomics and life sciences company founded in 1998 in the United States with 8,625 employees. The company develops and manufactures DNA sequencing and genetic analysis systems.

      BECTON, DICKINSON AND COMPANY

      Becton, Dickinson and Company is a public medical technology company founded in 1897 in the United States with 72,000 employees. The company manufactures and sells medical devices, laboratory equipment, and diagnostic products worldwide.

      CAREDX, INC.

      CareDx, Inc. is a public molecular diagnostics company founded in 1998 in the United States with 763 employees. The company develops and offers diagnostic solutions for transplant patients.

      DIASORIN S.P.A.

      DiaSorin S.p.A. is a public in vitro diagnostics company founded in 1968 in Italy with 3,242 employees. The company manufactures and distributes diagnostic products for clinical laboratories.

      MERCK KGAA

      Merck KGaA is a public pharmaceutical, chemical, and life sciences company founded in 1668 in Germany with 59,077 employees. The company operates globally in healthcare, life sciences, and performance materials sectors.

      HOLOGIC, INC.

      Hologic, Inc. is a private medical technology company founded in 1985 in the United States with 7,070 employees. The company develops and manufactures diagnostic and medical imaging products.

      EUROBIO SCIENTIFIC

      Eurobio Scientific is a public in vitro diagnostics company founded in 1997 in France with 343 employees. The company specializes in diagnostic reagents and laboratory solutions.

      Reasons to Buy this Report

      • Market Size & Growth Projections : Access detailed forecasts showing China's transplant diagnostics market growing from $55.4M (2026) to $62.9M (2031) at 5.9% CAGR, enabling informed investment and expansion decisions in this high-growth segment.
      • Competitive Landscape Analysis : Understand key players, market share distribution, and competitive strategies specific to China's transplant diagnostics sector, identifying partnership and acquisition opportunities in this emerging market.
      • Regulatory & Policy Insights : Gain comprehensive understanding of China's organ transplant regulations, government healthcare policies, and reimbursement frameworks that directly impact market dynamics and business strategy.
      • Technology Adoption Trends : Identify which diagnostic technologies (HLA typing, immunosuppressant monitoring, rejection detection) are gaining traction in Chinese hospitals and diagnostic centers, guiding product development priorities.
      • Regional Growth Opportunities : Discover high-potential geographic segments within China, including tier-2 and tier-3 city expansion opportunities, enabling targeted market entry and resource allocation strategies.

      Frequently asked questions

      What is the current size of Europe's transplant diagnostics market?

      Europe's transplant diagnostics market is valued at $55.4 million in 2026 and is projected to grow to $62.9 million by 2031.

      What is the growth rate of Europe's transplant diagnostics market?

      Europe's transplant diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 5.9% from 2026 to 2031.

      Which countries are driving growth in Europe's transplant diagnostics market?

      Key European markets including Germany, France, the United Kingdom, and Spain are leading adoption of advanced transplant diagnostic platforms and driving regional growth.

      What diagnostic technologies are most in demand across Europe?

      HLA typing, immunosuppressive monitoring, and donor-recipient compatibility testing are among the most sought-after diagnostic technologies in Europe's transplant sector.

      How do Europe's regulatory policies impact the transplant diagnostics market?

      Europe's mature regulatory environment and favorable reimbursement policies create a supportive framework for the adoption and expansion of transplant diagnostic innovations across the region.

      RESEARCH METHODOLOGY

      The objective of this study is to analyze the key market dynamics, including drivers, opportunities, constraints, challenges, and strategies employed by key players. We will track developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, to assess the competitive landscape of the transplant diagnostics market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
      To estimate the market size, both top-down and bottom-up approaches were utilized. The market breakdown and data triangulation were employed to determine the sizes of segments and subsegments.
      The four steps involved in estimating the market size are:

      Secondary Research

      In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

      Primary Research

      In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess prospects.
      The following is a breakdown of the primary respondents:

      Transplant Diagnostics Market Size, and Share

      Note 1: Other designations include sales, marketing, and product managers.
      Note 2: Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

      COMPANY NAME

      DESIGNATION

      Thermo Fisher Scientific Inc. (US)

      Sales Manager

      F. Hoffmann-La Roche AG (Switzerland)

      Product Manager

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the transplant diagnostics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry have been identified through extensive secondary research.
      • The revenues generated by leading players operating in the transplant diagnostics market have been determined through primary and secondary research.
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

      The research methodology used to estimate the market size includes the following:

      Transplant Diagnostics Market : Top-Down and Bottom-Up Approach

      Transplant Diagnostics Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the overall market size using the process described above, the total market was split into several segments and subsegments. To complete the overall market engineering process and obtain the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Transplant diagnostic procedures are used to determine donor-recipient compatibility to avoid the risk of immune rejection in a recipient. These procedures are adopted for donor-recipient cross-matching, subject profiling, genotyping, and other related diagnostic tests. Advanced genomic techniques (such as PCR and NGS) are increasingly used in transplant diagnostic procedures, alongside serological and other conventional techniques for immunocompatibility testing (such as antibody-antigen reactions and leucocyte assays).

      Key Stakeholders

      • Transplant diagnostic product manufacturing companies
      • Healthcare service providers (including hospitals, transplant centers, and blood transfusion centers)
      • Blood, tissue, and stem cell banks
      • Government organizations
      • Independent associations & regulatory authorities
      • R&D companies
      • Independent reference laboratories
      • Diagnostic laboratories
      • Clinical research organizations

      Report Objectives

      • To define, segment, and forecast the transplant diagnostics market by product & service, technology, application, type, end user, and region
      • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market 
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
      • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
      • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
      • To study the impact of AI on the market, along with the macroeconomic outlook for each region

      Available customizations:

      MarketsandMarkets offers the following customizations for this market report.

      Product Analysis

      • Product matrix, which provides a detailed comparison of the product portfolio of each company in the transplant diagnostics market

      Company Profiles

      • Additional five company profiles of players operating in the transplant diagnostics market.

      Country Information

      • Additional country-level analysis of the transplant diagnostics market

      Get the Full Transplant Diagnostics Market Report

      Full forecast, segment splits, and company analysis for all Transplant Diagnostics Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status